Recent News

574 News Items found
Dana Pe'er, Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute
Take a look back at some of the biggest cancer science stories from this past year.
Structure of an intermediate during the homologous recombination reaction.
The high-resolution views provided by cryo-electron microscopy are helping scientists learn how proteins and DNA collaborate to repair broken DNA.
Nadeem Riaz (left) and Jorge Reis-Filho (right)
Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
Systems biologist Joao Xavier in his lab
Finding
MSK researchers have shown for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.
SKI cell biologists Junmei Yi and Xuejun Jiang
In the Lab
Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.
An illustration of a reel of film
In the Lab
Grab your popcorn and pull up a chair for these video shorts of cell signaling in early mouse development.
MSK immunologist Ming Li.
In the Lab
Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.
MSK developmental biologist Lorenz Studer
Q&A
In an interview in September 2020, Dr. Studer spoke about what he hopes he and his fellow investigators can accomplish with this generous support.
Regulatory proteins (gold balls) bind to enhancer regions (light blue) and promoter regions (pink) of DNA to form clusters that enable transcription (purple).
Scientists at the Sloan Kettering Institute are learning how far-flung regions of genes connect to start the process of making proteins.
An illustration of a beta-amyloid plaque among the neurons in a brain.
Article
An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.